The news that pharmacy-benefits manager Express Scripts is ditching the world's biggest diabetes-focused company came as a surprise. It will no longer use Novo Nordisk's Victoza, or any of its ...
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday. The move is aimed at addressing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results